Related references
Note: Only part of the references are listed.Splicing factors: Insights into their regulatory network in alternative splicing in cancer
Jun-Xian Du et al.
CANCER LETTERS (2021)
RREB1 Integrates TGF-beta and RAS Signals to Drive EMT
Laurent Fattet et al.
DEVELOPMENTAL CELL (2020)
Multimodal treatment of hepatocellular carcinoma
M. M. Kirstein et al.
INTERNIST (2020)
Knockdown of LINC00662 represses AK4 and attenuates radioresistance of oral squamous cell carcinoma
Yangzong Chen et al.
CANCER CELL INTERNATIONAL (2020)
Cyclin Y binds and activates CDK4 to promote the G1/S phase transition in hepatocellular carcinoma cells via Rb signaling
Lei Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme
Li-chong Wang et al.
FRONTIERS IN ONCOLOGY (2020)
SNRPB-mediated RNA splicing drives tumor cell proliferation and stemness in hepatocellular carcinoma
Yu-Ting Zhan et al.
Aging-US (2020)
Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq
Fan Zhang et al.
BMC BIOINFORMATICS (2020)
Diagnostic, progressive and prognostic performance of m6A methylation RNA regulators in lung adenocarcinoma
Zhizhi Zhuang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer
Ledong Wan et al.
GUT (2019)
Treatment Strategies for Hepatocellular CarcinomaA Multidisciplinary Approach
Isabella Lurje et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling (vol 17, pg 81, 2014)
Tomoyo Okada et al.
NATURE CELL BIOLOGY (2019)
LBX2-AS1 is activated by ZEB1 and promotes the development of esophageal squamous cell carcinoma by interacting with HNRNPC to enhance the stability of ZEB1 and ZEB2 mRNAs
Yanshan Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
The Function of RAS Mutation in Cancer and Advances in its Drug Research
Shijie Chen et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
Weidong Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma
Hiroaki Takaya et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival
Josep M. Llovet et al.
JOURNAL OF HEPATOLOGY (2019)
hnRNPC regulates cancer-specific alternative cleavage and polyadenylation profiles
Harry Fischl et al.
NUCLEIC ACIDS RESEARCH (2019)
Long noncoding RNA EMS connects c-Myc to cell cycle control and tumorigenesis
Chenfeng Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Immunotherapy for hepatocellular carcinoma: Current and future
Michael P. Johnston et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma
Ziyu Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Goals and targets for personalized therapy for HCC
Thomas Couri et al.
HEPATOLOGY INTERNATIONAL (2019)
Impact of RAS mutation subtype on clinical outcome-a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer
Marcel Wiesweg et al.
ONCOGENE (2019)
Polymorphisms in RAS/RAF/MEK/ERK Pathway Are Associated with Gastric Cancer
Patricio Gonzalez-Hormazabal et al.
GENES (2019)
Hepatocellular Carcinoma
Yun S. Kim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Predictors of 5 year survival rate in hepatocellular carcinoma patients
Arash Sarveazad et al.
JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2019)
Chemotherapy for hepatocellular carcinoma: current status and future perspectives
Masafumi Ikeda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2018)
Design and discovery of thioether and nicotinamide containing sorafenib analogues as multikinase inhibitors targeting B-Raf, B-RafV600E and VEGFR-2
Shaofeng Sun et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Alternative splicing and cancer metastasis: prognostic and therapeutic applications
Diego M. Marzese et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
Serum exosomal hnRNPH1 mRNA as a novel marker for hepatocellular carcinoma
Hong Xu et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
The Long Noncoding RNA Cancer Susceptibility 9 and RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein L Form a Complex and Coregulate Genes Linked to AKT Signaling
Marcel Klingenberg et al.
HEPATOLOGY (2018)
Liver Transplantation and Liver Resection for Cirrhotic Patients with Hepatocellular Carcinoma: Comparison of Long-Term Survivals
Felix Krenzien et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2018)
Linalool induces cell cycle arrest and apoptosis in HepG2 cells through oxidative stress generation and modulation of Ras/MAPK and Akt/mTOR pathways
Boris Rodenak-Kladniew et al.
LIFE SCIENCES (2018)
Multicenter Study of Staging and Therapeutic Predictors of Hepatocellular Carcinoma Recurrence Following Transplantation
Theodore H. Welling et al.
LIVER TRANSPLANTATION (2018)
MiR-744-5p inducing cell death by directly targeting HNRNPC and NFIX in ovarian cancer cells
Michael Kleemann et al.
SCIENTIFIC REPORTS (2018)
Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
Laura M. Urbanski et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2018)
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response
Yusheng Wu et al.
EMBO JOURNAL (2018)
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Pattern of disease recurrence and its implications for postoperative surveillance after curative hepatectomy for hepatocellular carcinoma: experience from a single center
Kit-Fai Lee et al.
HEPATOBILIARY SURGERY AND NUTRITION (2018)
Scutellariae Radix and Coptidis Rhizoma Improve Glucose and Lipid Metabolism in T2DM Rats via Regulation of the Metabolic Profiling and MAPK/PI3K/Akt Signaling Pathway
Xiang Cui et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Systemic therapy for hepatocellular carcinoma: beyond sorafenib
Patrick Boland et al.
CHINESE CLINICAL ONCOLOGY (2018)
Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
Victoria Tovar et al.
GUT (2017)
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2017)
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
Gonzalo Sapisochin et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Alternative splicing as a regulator of development and tissue identity
Francisco E. Baralle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Identification of Differentially Expressed K-Ras Transcript Variants in Patients With Leiomyoma
Nooshin Zolfaghari et al.
REPRODUCTIVE SCIENCES (2017)
From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world
Dimitrios Dimitroulis et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Mutational analysis of the RAS/RAF/MEK/ERK signaling pathway in 260 Han Chinese patients with cervical carcinoma
Yang Zou et al.
ONCOLOGY LETTERS (2017)
Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma
Sufang Yang et al.
ONCOLOGY LETTERS (2017)
Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation
J. Xu et al.
ONCOGENESIS (2017)
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015
Tomi Akinyemiju et al.
JAMA ONCOLOGY (2017)
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
Ping Wee et al.
CANCERS (2017)
GSK3β-dependent cyclin D1 and cyclin E1 degradation is indispensable for NVP-BEZ235 induced G0/G1 arrest in neuroblastoma cells
Shan-Ling Liu et al.
CELL CYCLE (2017)
Cholesterol Enhances Colorectal Cancer Progression via ROS Elevation and MAPK Signaling Pathway Activation
Caihua Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
K-RAS and N-RAS mutations in testicular germ cell tumors
Bekir Muhammet Hacioglu et al.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2017)
Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions
Yuan Shen et al.
EMBO REPORTS (2017)
Prognostic alternative mRNA splicing signature in non-small cell lung cancer
Yuan Li et al.
CANCER LETTERS (2017)
HNRNPC as a candidate biomarker for chemoresistance in gastric cancer
Hao Huang et al.
TUMOR BIOLOGY (2016)
TGF-β Tumor Suppression through a Lethal EMT
Charles J. David et al.
CELL (2016)
The hnRNP family: insights into their role in health and disease
Thomas Geuens et al.
HUMAN GENETICS (2016)
Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis
Antonio Facciorusso et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2016)
Treating cancer with selective CDK4/6 inhibitors
Ben O'Leary et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC
Lei Li et al.
ONCOLOGY LETTERS (2016)
The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications
Benedicte Delire et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents
Xinbing Sui et al.
CANCER LETTERS (2014)
Ras/Raf/MEK/ERK pathway activation in childhood acute lymphoblastic leukemia and its therapeutic targeting
Thomas Knight et al.
FRONTIERS IN ONCOLOGY (2014)
Direct Competition between hnRNP C and U2AF65 Protects the Transcriptome from the Exonization of Alu Elements
Kathi Zarnack et al.
CELL (2013)
Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma
Ao-Xue Wang et al.
IUBMB LIFE (2013)
Regulatory networks defining EMT during cancer initiation and progression
Bram De Craene et al.
NATURE REVIEWS CANCER (2013)
Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer
K. Vuoriluoto et al.
ONCOGENE (2011)
H-ras Consensus Sequence and Mutations in Primary Hepatocellular Carcinomas of Lemurs and Lorises
J. M. Cullen et al.
VETERINARY PATHOLOGY (2011)
Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma
Huaqing Cui et al.
BMC CANCER (2010)
Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis
Wei Sun et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention
F Chang et al.
LEUKEMIA (2003)
Share Paper
